Register


Create a profile to access all of our events, including options to sign up for our in person meetings and to view the online content from our past conferences!


Video Platform

View all the content from the last 12 months

MD Newsletter

Stay up to date with everything MD Education

Tickets & Events

Save your space and register for our future events

Select what applies to you




Login

Gaining access to MD Education’s premium offerings is only a button away! Enter your email and password to get educated.

We're evolving!

The website is currently being upgraded to include our new suite of offerings. Check back at the end of the month for a breakdown of our new services!


Questions? Contact us at:


office@md-education.com

Want Cookies?


Currently, we're using cookies for tracking purposes. By tracking, we mean what pages of MD Education you visit, what forms you submit and how you interact with our site. We do not sell this data to anybody. Currently, the Cookies we use are needed to collect form data through HubSpot.


If you'd like to see what we do with your data, head over to our Privacy Policy


Inaugural

Thank you for registering to our ASH Satillite Symposium!

Please check your emails for registration confirmation.


Women in Hematology

US Focus Meeting

Updating Knowledge & Clinical Practice in 2025


Hilton La Jolla Torrey Pines, 10950 N Torrey Pines Rd, La Jolla, CA 92037

November 7 - 8, 2025

Interested in supporting this meeting? Reach out to us here:

=

Co-chair

Sanam Loghavi, MD

MD Anderson Cancer Center, Houston, TX

=

Co-chair

Loretta Nastoupil, MD

Southwest Oncology, Durango, CO

=

Co-chair

Krina Patel, MD

MD Anderson Cancer Center, Houston, TX

Dear Colleagues and Friends,


We are delighted to extend our warmest invitation to the multinational congress Women in Hematology US Focus 2025, to be held at Hilton La Jolla Torrey Pines, 10950 N Torrey Pines Rd, La Jolla, CA 92037 on November 7th, 2025 to November 8th, 2025.


This meeting provides pivotal collaboration aimed at advancing Women in Hematology research and patient treatment.


This meeting presents an opportunity for medical professionals to engage in the exchange of knowledge, expertise, and insights, as well as networking with leading experts from around the world.


Engage in riveting presentations, participate in thought-provoking debates, round-table discussions, and connect with peers at informal social gatherings.



People stood in a circle, smiling, with a cup of water

Agenda & Faculty

Women in Hematology US Focus Meeting, Friday, November 7, 2025 - Saturday, November 8, 2025

7:30 AM

Registration Opens

Session 1: Myeloid Neoplasms Part I - Novel Biomarkers for Diagnosis and Prognosis in Myeloid Neoplasms

9:00 AM

Contemporary Classification of Myeloid Neoplasms

=

Sanam Loghavi, MD

MD Anderson Cancer Center, Houston, TX

9:20 AM

Risk-Adapted Management of Clonal Hematopoiesis – Are We There Yet?

=

Kelly Bolton, MD

Washington University School of Medicine, St. Louis, MO

9:40 AM

Prognostication, Risk Stratification and Disease Modifying Strategies Myelodysplastic Neoplasms/Syndromes

=

Amy DeZern, MD

Johns Hopkins Medicine, Baltimore, MD

10:00 AM

Diagnosis and Frontline Treatment Strategies for ET, PV & MF

=

Gabriela Hobbs, MD

Massachusetts General Hospital, Boston, MA

10:20 AM

Panel Discussion

10:40 AM

Coffee Break

Session 2: Myeloid Neoplasms Part II - Novel Therapies and Risk-adapted Personalized Treatment

11:00 AM

Contemporary Treatment Paradigm for Acute Myeloid Leukemia with Targetable Genetic Alterations

=

Courtney DiNardo, MD

MD Anderson Cancer Center, Houston, TX

11:20 AM

MRD- Directed Treatment Strategies for Acute Myeloid Leukemia

=

Jessica Altman, MD

Northwestern University Feinberg School of Medicine, Chicago, IL

11:40 AM

Innovating for Impact: A Career Blueprint for Aspiring Leukemia Physician Scientists

=

Ann-Kathrin Eisfeld, MD

OSU Comprehensive Cancer Center, Columbus, OH

12:00 PM

Panel Discussion

12:20 PM

Industry Supported Independent Expert Discussion

1:05 PM

Lunch Break + Faculty and Fellow Photo

Session 3: Lymphoid Neoplasms Part I - Future Directions for Drug Development in Lymphoma

1:55 PM

Leading the Way: How the Cooperative Groups Will Transform the Treatment for Lymphoma in the Next 5 Years

=

Sonali Smith, MD

The University of Chicago Medicine, IL

2:15 PM

Partnering with Disease Organizations such as LRF to Drive Research Initiatives

=

Ann LaCasce, MD

Dana-Farber Cancer Institute, Boston, MA

2:35 PM

Risk Stratification and MRD in Lymphoma, Current Application and Future Directions?

=

Carla Casulo, MD

University of Rochester, NY

2:55 PM

Where to Use Bispecific Antibodies Now in Lymphoma, and How This Will Evolve Over the Next Few Years

=

Julie Vose, MD

University of Nebraska Medical Center, Omaha, NE

3:15 PM

Leveraging Community Sites to Improve Efficiency in Drug Development, Lessons Learned and Future Directions

=

Tara Graff, MD

Mission Cancer + Blood, Des Moines, IA

3:35 PM

Contemporary Paradigm of Frontline Treatment for CLL

=

Catherine Coombs, MD

UCI Health, California

3:55 PM

Panel Discussion

4:15 PM

Coffee Break

Session 4: Lymphoid Neoplasms Part II - Translational Science in Lymphoma

4:35 PM

Next Generation Trials in MCL, Roadmap to Conducting Investigator Lead Trials in a Rare Tumor

=

Anita Kumar, MD

Memorial Sloan Kettering Cancer Center, New York, NY

4:55 PM

Tackling the Next Frontier, Promising Advances in T-cell Lymphoma

=

Neha Mehta-Shah, MD

Washington University St. Louis, Missouri

5:15 PM

What’s Next in Hodgkin Lymphoma?

=

Alison Moskowitz, MD

Memorial Sloan Kettering Cancer Center, New York, NY

5:35 PM

Developing Targeted Therapies for Lymphoma, Running a Successful Lab

=

Jennifer Amengual, MD

The Herbert Irving Comprehensive Cancer Center, New York, NY

5:55 PM

Panel Discussion

6:15 PM

Adjourn